written by Stephan Grabner
This past summer, as Ebola spread through parts of West Africa, I was working for a tech start-up in Ghana. Although the disease hadn’t been confirmed in Ghana, I – and certainly my advisors at UNC– kept a close eye on the development. Ebola Hemorrhagic Fever first spread to humans in the 1970s and has since killed thousands in periodic outbreaks. There is currently no known cure for the virus, which is transmitted via bodily fluids and has a fatality rate of roughly 50% in the case of the present epidemic.